Welcome to LookChem.com Sign In|Join Free
  • or
3-(piperidin-1-yl)propyl 4-methylbenzenesulfonate is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

748092-05-9

Post Buying Request

748092-05-9 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

748092-05-9 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 748092-05-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 7,4,8,0,9 and 2 respectively; the second part has 2 digits, 0 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 748092-05:
(8*7)+(7*4)+(6*8)+(5*0)+(4*9)+(3*2)+(2*0)+(1*5)=179
179 % 10 = 9
So 748092-05-9 is a valid CAS Registry Number.

748092-05-9Relevant academic research and scientific papers

QUINAZOLINE DERIVATIVE

-

, (2017/07/04)

Provided are a quinazoline derivative, a pharmaceutical composition containing the same, a method for preparation of said derivative, and an application of same as an anti-cancer drug.

Thiazolyl-Benzimidazoles

-

Page/Page column 28, (2010/07/04)

The invention is directed to compounds of formula (1) and pharmaceutically acceptable salts thereof, methods for the preparation thereof, and methods of use thereof.

Benzisoxazolyl-, pyridoisoxazolyl- and benzthienyl-phenoxy derivatives useful as D4 antagonists

-

, (2008/06/13)

The compounds are of the class of benzisoxazolyl-, pyridoisoxazolyl- and benzthienyl-phenoxy derivatives, useful as D4 antagonists. Said compounds are useful for the treatment of medical conditions mediated by inhibition of D4 receptor. These conditions comprise, for example, Attention Deficit Hyperactivity Disorder, Obsessive-Compulsive Disorder, Psychoses, Substance Abuse, Substance Dependence, Parkinson's Disease, Parkinsonism, Tardive Diskinesia, Gilles de la Tourette Syndrome, Conduct Disorder, and Oppositional Defiant Disorder. A further aspect of the invention is to provide a pharmaceutical composition, intermediates, and a method of making said class of compounds.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 748092-05-9